| Cell line name | A2780-cisR |
|---|---|
| Synonyms | A2780-CISR; A2780/cisR; A2780cisR; A2780(cisR) |
| Accession | CVCL_H745 |
| Resource Identification Initiative | To cite this cell line use: A2780-cisR (RRID:CVCL_H745) |
| Comments | Population: African American. Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP). Omics: Metabolome analysis. Derived from site: In situ; Ovary; UBERON=UBERON_0000992. |
| Sequence variations |
|
| Disease | Ovarian endometrioid adenocarcinoma (NCIt: C7979) Endometrioid carcinoma of ovary (ORDO: Orphanet_454723) |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
| Hierarchy | Parent: CVCL_0134 (A2780) |
| Sex of cell | Female |
| Age at sampling | Age unspecified |
| Category | Cancer cell line |
| Cross-references | |
| Cell line databases/resources | cancercelllines; CVCL_H745 |
| Chemistry resources | ChEMBL-Cells; CHEMBL3307508
ChEMBL-Targets; CHEMBL614023 PubChem_Cell_line; CVCL_H745 |
| Encyclopedic resources | Wikidata; Q54606563 |
| Metabolomic databases | MetaboLights; MTBLS156
MetaboLights; MTBLS1014 |
| Polymorphism and mutation databases | Cosmic; 688091 |
| Entry history | |
| Entry creation | 11-Feb-2013 |
| Last entry update | 05-Oct-2023 |
| Version number | 21 |